![]() Cerner’s overall revenue suffered a 3% decline in 1H 2020 (versus 1H 2019). ![]() This growth was aided by success in Europe, particularly in the UK and Nordics where it won new contracts. Whilst MEDITECH has considerably lower revenue than Cerner, its international revenue is broadly similar as a share of its total revenue.īy contrast, Allscripts and MEDITECH each has international business that is comparable in terms of revenues, but as a share of overall revenues, international is much less important for Allscripts.Īllscripts’ international revenue was lower than Epic, Cerner and Meditech in 2018, however, its growth in 2019 enabled it to overtake MEDITECH and become the third largest of the four vendors in 2019.Ĭerner’s international revenues fell marginally as a proportion of its total business in 2019 (11.5%, down from 11.9% in 2018), although revenues grew in absolute terms by 3%. Cerner has by far the highest revenue at more than $650M in 2019, representing 12% of its business. In this insight we assess how the top US acute EHR vendors, namely Cerner, Epic, Allscripts and MEDITECH (+85% share of US acute market in terms of revenues), have progressed specifically on the third point, international expansion.Īs highlighted below, there is a significant variance amongst the big four in terms of revenue and share of business outside the US. Aggressive acquisition strategies that drive market share expansion.Expanding what is provided within “standard” EHR offerings.Diversifying product portfolios into related areasand new verticals.Signify Research has previously outlined some of the key strategies US EHR vendors could employ to help maintain historical growth as their domestic core-EHR market started to saturate. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |